Home » Newsletters » BioWorld

BioWorld

Sep. 18, 2000

View Archived Issues

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 24, 2025.
Moderna expands mRNA tech to latent viruses, cancer, rare disease
BioWorld
Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
Otsuka licenses Harbour’s bispecific T-cell engager for $670M
BioWorld
Harbour Biomed is out-licensing its B-cell maturation antigen and CD3 bispecific T-cell engager HBM-7020 for autoimmune diseases to Otsuka Pharmaceutical Co. Ltd....
Revmed goes global with $2B in capital for RAS(ON) inhibitors
BioWorld
Taking an unconventional path to market for its targeted therapies for RAS-addicted cancers, Revolution Medicines Inc. secured access to $2 billion in capital to...